CLINICAL TRIALS PROFILE FOR COMBOGESIC IV
✉ Email this page to a colleague
All Clinical Trials for COMBOGESIC IV
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT07225140 ↗ | A Study of Combogesic 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery | NOT_YET_RECRUITING | AFT Pharmaceuticals, Ltd. | PHASE3 | 2026-02-01 | Combogesic 325 contains a combination of ibuprofen and acetaminophen. The purpose of this study is to compare the pain relief effects of Combogesic 325mg and acetaminophen and to evaluate the safety of Combogesic 325mg in adolescents between the ages of 12 and \ |
| NCT07225634 ↗ | A Study of Combogesic IV (Intravenous) in Pediatric Patients With Acute Pain | NOT_YET_RECRUITING | AFT Pharmaceuticals, Ltd. | PHASE3 | 2026-02-01 | Combogesic IV is an intravenous medicine (given by vein) containing a combination of two pain relief (analgesic) medicines called ibuprofen and acetaminophen. The goal of this clinical trial is to study the way that the body processes and clears the intravenous infusion of Combogesic IV and that it is safe to be used in children and adolescents between the ages of 2 and \ |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for COMBOGESIC IV
Condition Name
Clinical Trial Locations for COMBOGESIC IV
Trials by Country
Clinical Trial Progress for COMBOGESIC IV
Clinical Trial Phase
Clinical Trial Sponsors for COMBOGESIC IV
Sponsor Name
